Literature DB >> 2125228

A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women.

J S Marks1, J P Koplan, C J Hogue, M E Dalmat.   

Abstract

Research has shown that pregnant women who smoke cigarettes increase their risk of having low birthweight (LBW) infants. Recent randomized trials indicate that women who quit smoking early in pregnancy reduce their risk of delivering a LBW infant. Using various sources, we estimated the cost-effectiveness of a smoking cessation program for preventing LBW and perinatal mortality. Assuming the program would cost $30 a participant and that 15% of the participants would quit smoking, we determined that a program offered to all pregnant smokers would shift 5,876 LBW infants to normal birthweight and would cost about $4,000 for each LBW infant prevented. Since infants born to smokers are at 20% greater risk for a perinatal death, a smoking cessation program could prevent 338 deaths at a cost of $69,542 for each perinatal death averted. Compared with the costs of caring for these LBW infants in a neonatal intensive care unit (NICU), smoking cessation programs would save $77,807,054, or $3.31 per $1 spent. The ratio of savings to costs increases to more than six to one when we include reducing long-term care for infants with disabilities secondary to LBW in the benefits from smoking cessation programs. These findings argue for routinely including smoking cessation programs in prenatal care for smokers.

Entities:  

Mesh:

Year:  1990        PMID: 2125228

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  37 in total

Review 1.  Helping pregnant smokers quit: meeting the challenge in the next decade.

Authors:  C T Orleans; R W Johnson; D C Barker; N J Kaufman; J F Marx
Journal:  West J Med       Date:  2001-04

Review 2.  The limited incorporation of economic analyses in clinical practice guidelines.

Authors:  Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

3.  The use of pharmacotherapies for smoking cessation during pregnancy.

Authors:  N L Benowitz; D A Dempsey; R L Goldenberg; J R Hughes; P Dolan-Mullen; P L Ogburn; C Oncken; C T Orleans; T A Slotkin; H P Whiteside; S Yaffe
Journal:  Tob Control       Date:  2000       Impact factor: 7.552

Review 4.  Preventive mental health and substance abuse programs and services in managed care.

Authors:  Sharon L Dorfman; Shelagh A Smith
Journal:  J Behav Health Serv Res       Date:  2002-08       Impact factor: 1.505

Review 5.  Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage.

Authors:  K E Warner
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

6.  Maternal smoking and adverse birth outcomes among singletons and twins.

Authors:  H Pollack; P M Lantz; J G Frohna
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

7.  The health benefits of smoking cessation for adult smokers and for pregnant women in Taiwan.

Authors:  C P Wen; T Y Cheng; C-L Lin; H-N Wu; D T Levy; L-K Chen; C-C Hsu; M P Eriksen; H-J Yang; S P Tsai
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

8.  Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy.

Authors:  Krista M Perreira; Kalena E Cortes
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

9.  Medicaid reimbursement for prenatal smoking intervention influences quitting and cessation.

Authors:  R Petersen; J M Garrett; C L Melvin; K E Hartmann
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

10.  Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States.

Authors:  Hamisu M Salihu; Muktar H Aliyu; Bosny J Pierre-Louis; Greg R Alexander
Journal:  Matern Child Health J       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.